Overview of hadron therapy: rationales, present status and future prospects
-
D.T.L. Jones
The rationales for hadron therapy are based on the physical selectivity and biological effects of the respective beams. Fastneutron therapy began as long ago as 1938 and subsequently proton, alpha particle, heavy ion, pion and neutron capture therapy have beenused. To date it is estimated that in excess of 50000 peoplehave undergone some form of hadron therapy. In the future it isexpected that fast neutron therapy will be used for selected tumourtypes for which neutrons are known to show improved cure rates. Thefuture trends in charged particle therapy will be driven by increasingcommercialization. The future of neutron capture therapy will dependon current clinical trials with epithermal neutron beams and thedevelopment of new tumour-seeking drugs.
© 2015 Oldenbourg Wissenschaftsverlag GmbH, Rosenheimer Str. 145, 81671 München
Articles in the same Issue
- Preface: Nuclear Data for Medical Applications
- Nuclear data for medical applications: an overview
- Overview of nuclear data libraries and online services
- In vivo functional imaging with SPECT and PET
- Dosimetry related to SPECT and PET applications
- Nuclear data relevant to the production and application of diagnostic radionuclide
- Overview of hadron therapy: rationales, present status and future prospects
- Hadrons (protons, neutrons, heavy ions) in radiation therapy: rationale, achievements and expectations
- What accuracy is required and can be achieved in radiation therapy (review of radiobiological and clinical data)
- Fast neutron and proton therapy sources
- Reference dosimetry for fast neutron and proton therapy
- Medium energy neutron and proton nuclear data for therapy
- Therapeutic radionuclides and nuclear data
- Overview of nuclear reaction models used in nuclear data evaluation
- Model calculations and evaluation of nuclear data for medical radioisotope production
- Nuclear reactions in proton, neutron, and photon radiotherapy
- A review of radiation dosimetry applications using the MCNP Monte Carlo code
Articles in the same Issue
- Preface: Nuclear Data for Medical Applications
- Nuclear data for medical applications: an overview
- Overview of nuclear data libraries and online services
- In vivo functional imaging with SPECT and PET
- Dosimetry related to SPECT and PET applications
- Nuclear data relevant to the production and application of diagnostic radionuclide
- Overview of hadron therapy: rationales, present status and future prospects
- Hadrons (protons, neutrons, heavy ions) in radiation therapy: rationale, achievements and expectations
- What accuracy is required and can be achieved in radiation therapy (review of radiobiological and clinical data)
- Fast neutron and proton therapy sources
- Reference dosimetry for fast neutron and proton therapy
- Medium energy neutron and proton nuclear data for therapy
- Therapeutic radionuclides and nuclear data
- Overview of nuclear reaction models used in nuclear data evaluation
- Model calculations and evaluation of nuclear data for medical radioisotope production
- Nuclear reactions in proton, neutron, and photon radiotherapy
- A review of radiation dosimetry applications using the MCNP Monte Carlo code
